Registry following people treated for brain blood vessel problems with Phenox devices
Follows people with brain aneurysms or vessel damage treated with Phenox devices.
Plain-language title generated from the registry record
Registry title: Targeting Real World Usage In Stroke Treatment
Key facts
- Where
- Catania, Milan, and Naples, ItalySee the 3 sites
Where in Italy
- Cannizzaro Hospital in CataniaCatania, ItalyNot yet recruiting
- Asst Grande Ospedale Metropolitano Niguarda-MilanoMilan, ItalyNot yet recruiting
- Antonio Cardarelli Hospital- NaplesNaples, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Phenox GmbH
- Trial code
- NCT07474935
- Record updated
- 16 March 2026
- Original description
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.Read full original descriptionShow less
TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.
The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.
Inclusion: Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),; Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.
Exclusion: Participation in an interventional study modifying standard care management for all relevant indications,.